Clinico-Pathological observational study of the spectrum of tumours of mesenchymal origin in the female genital tract - a prospective study in a tertiary care hospital
Abstract
Aim: The current study aims to evaluate uterine tumours of mesenchymal origin, their incidence, and to analysethe various gamut of clinical and histopathological findings which lead to diagnosis and optimal management.
Material & Methods: A two year prospective study was conducted in the department of pathology in a tertiary care teaching hospital on mesenchymal tumors of the female genital tract, which were grossed, processed and reported. A case sheet for study was studied and analysed for statistical data.
Result: 172 cases were reported in period of 2 years, common in multiparous women in their 4th decade of life, presented with menorrhagia, pain and dysmenorrhea, amongst which 95.93% were benign, 4.07% were diagnosed malignant on histopathology. Leiomyosarcoma, endometrial stromal sarcoma, smooth muscle tumour of uncertain malignant potential, carcinosarcoma were noted.
Conclusion: Hysterectomy is routine procedure surgical procedure for gynaecological cause, and histopathological diagnosis is mandatory for multidisciplinary management of patient. Though the immunohistochemistry are supportive for diagnosis, but the morphological features trumphs all the ancillary testing required for diagnosis of mesenchymal origin of tumours.
Downloads
References
2. Gemma Toledo and Esther Oliva . Smooth muscle tumors of the uterus: A practical approach. Archives of Pathology and laboratory medicine: April 2008, Vol. 132, No. 4, pp. 595-605.[pubmed]
3. Rein MS, Barbieri RL, Friedman AJ. Progesterone: A critical role in pathogenesis of uterine myomas. Am J ObstGynecol 1995;172(1)14-8.[pubmed]
4. Witherspoon T J. The interrelationship between ovarian follicle cysts, hyperplasia of endometrium and fibromyomata. Surg GynecolObstet 1933; 56: 1026-35.
5. Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ. Peritoneal dissemination complicating morecellation of uterine mesenchymal neoplasms.PLOS ONE 2012;7:e 50058.[pubmed]
6. Gupta S, Manyonda I. Hysterectomy for benign gynecological diseases. Current ObstetGynaecol2006;16:147- 53.
7. Rani S. V. R, Thomas S. Leiomyoma, a major cause of abnormal uterine bleeding. J of Evolution of Medical and Dental Sciences.2013;2:2626-30.
8. John A, Rock MD, Jhon D, Thompson MD; Telinds’s Operative Gynaecology. 1st Edition Lippincott- Raven place.
9. Verma D, Singh P, Kulshrestha R. Analysis of histopathological examination of the hysterectomy specimens in a north Indian teaching institute. International Journal of Research in Medical Sciences. 2016;4(11):4753-8.
10. Siwatch S, Kundu R, Mohan H, Huria A. Histopathologic audit of hysterectomy specimens in a tertiary care hospital. Sri Lanka Journal of Obstetrics and Gynaecology. 2013;34(4):155-58.
11. Begum S, Khan S. Audit of leiomyoma uterus at Khyber Teaching Hospital, Peshawar. J Ayub Med Coll 2004;16(2):46-9.[pubmed]
12. Mangala G, Geetha M, Srinivasa M, Vedavathy N. “Clinicopathological study of uterine leiomyomas in hysterectomy specimens”. Journal of Evolution of Medical and Dental Sciences 2013; Vol. 2, Issue 46, November 18; Page: 9002-9009.
13. Lahori M, Malhotra AS, Khauria A, Goswami KC. Clinicopathological spectrum of uterine Leiomyomas in state of Northern India: A hospital based study. Int J.Reprod Contracept Obstet Gynecol.2017;5 (7):2295-9.
14. Kulkarni MR, DuttaI, DuttaDK. Clinicopathological study of uterine Leiomyomas: a multicentric study in rural population. J ObstetGynecol India.2016;66(1):412-6.[pubmed]
15. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of reproductive organs, 4th ed. Lyon, France: International agency for research on cancer, 2014
16. Bell SW, Kempson RL and Hendrickson MR: Problematic uterine smooth muscle neoplasms A clinicopathologic study of 213 cases. Am J SurgPatholo. 1994; 18:535–558.[pubmed]
17. KalogiannidisI,Stavrakis T,Dagklis T,Petousis S, Nikolaidou C,Rousso D. Clinicopathological study of atypical leiomyomas: benign variant leiomyoma or smooth muscle tumour of uncertain malignant potential. Oncology letter.2016; 11. 1425-1428.[pubmed]
18. Shapiro A, Ferenczy A, Turcotte R, Bruchim I, Gotlieb WH. Uterine smooth muscle tumor of uncertain malignant potentioa; metastasizing to the humerus as high grade leiomyosarcoma. Gynecol Oncol 2004;94: 818-20.[pubmed]
19. Amant F, Moerman P, Vergote I. Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis. Int J Gynecol Cancer 2005; 15: 1210-2.[pubmed]
20. D’ Angelo E, Prat J. Uterine sarcoma: A review. Gynecol Oncol 2010;116: 131-9.[pubmed]
21. A. Hrzenjak, “JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas,” Orphanet Journal of rare diseases, 2016; vol. 11, no.1, p.15.[pubmed]
22. R. H. Ali and M. R ouzbahman,"Endometrial stromal tumours revisited: an update based on the 2014 WHO classification,” Journal of Clinical pathology, 2015; vol.68, no. 5, pp.325-332,.
23. Arend R, Doneza JA, Wright JD. Uterine carcinosarcoma. CurrOpin Onco.2011;23: 531-536.[pubmed]
24. Singh R. Review literature on uterine carcinosarcoma. J Can Res Ther2014;10:461-68.[pubmed]
OAI - Open Archives Initiative
